Calyx doubles IPO amount to Rs 200 cr
Targets to raise IPO before March 2013
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cabinet clears SAP-based pharma pricing policy
But Supreme Court hearing on Nov 27 could still ruin the plot
Industry awaits final word on ‘brand ban’
After the hue and cry over the Ministry of Health and Family Welfare's directive to stop granting or renewing manufacturing…
Singapore A global-Asia pharmaceutical hub
Lee Eng Keat, International Director (Asia Pacific) of the Singapore Economic Development Board (EDB), speaks about the synergy…
Discover the hidden OTC Gems of the Indian pharma market
Sreedevi Yallamrazu, Sr Strategic Analyst, CubeX, a division of Sorento Healthcare Communications, says that new business models…
Leveraging social media for success
B Sriram, Executive Director– Healthcare, Direxions Marketing Solutions, advises Indian pharma to deploy social media for…
Patents – why and when?
Milind Sathe, Deputy General Manager – Projects, Unichem Laboratories gives a rundown on patents, its uses, objectives,…
GOM’s proposed simple average pricing to result in sharper price cuts
AIOCD-PharmaTrac data also shows some companeis will have a lower impact under SAP
‘Criteria of speaker selection is important to convey the quality level’
Dr Srinubabu Gedela, Director, OMICS Group of Conferences, reveals more to Sachin Jagdale about pharma conferences and their plans…
Pharmexcil expects Ministry notification on branding for drug exports within a week
Notification to clarify status and expected to bring relief to pharma exporters